Johnson & Johnson Establishes Foundation To Support Terracotta Warriors
This article was originally published in PharmAsia News
Executive Summary
Johnson & Johnson and the Museum of Terra-cotta Warriors and Horses of Qin Shihuang have announced that genuine terracotta warriors will be displayed in the drug company's Olympics exhibition center during the Beijing Olympic Games. At the same time, both parties will continue to deepen their eight-year cooperation by jointly setting up a global foundation fund that will be used in four aspects: to strengthen R&D of the relics and terracotta site protection; enhance R&D personnel's education and training; communicate the knowledge of relic protection; and boost academic development by establishing awards, scholarships and qualification authentication. Johnson & Johnson officials say that establishing the fund is a reflection of its social responsibility toward China's priceless heritage. (Click here for more - Chinese Language)
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.